Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 12128140 Extended release pharmaceutical formulation

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
0
Date Filed
March 5, 2020
0
Date of Patent
October 29, 2024
0
Patent Application Number
17442239
0
Patent Citations
‌
US Patent 8114383 Abuse-proofed dosage form
0
‌
US Patent 8137711 Methods of treating neuropathy
0
‌
US Patent 8309060 Abuse-proofed dosage form
0
‌
US Patent 9272037 Method to treat premature ejaculation in humans
0
‌
US Patent 9533982 Substituted bicyclic heteroaryl carboxamide analogs as mGluR5 negative allosteric modulators
0
‌
US Patent 9650362 Inhibitors
0
‌
US Patent 9867830 Use of (2R, 6R)-hydroxynorketamine, (S)-dehydronorketamine and other stereoisomeric dehydro and hydroxylated metabolites of (R,S)-ketamine in the treatment of depression and neuropathic pain
0
‌
US Patent 10441544 Extended release pharmaceutical formulation
0
‌
US Patent 10744094 Extended release pharmaceutical formulation
0
‌
US Patent 11045424 Extended release pharmaceutical formulation
0
•••
Patent Inventor Names
Paul William Glue
0
Peter William Surman
0
Natalie June Medlicott
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
12128140
0
Patent Primary Examiner
‌
Aradhana Sasan
0

Find more entities like US Patent 12128140 Extended release pharmaceutical formulation

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo